Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sees Significant Decrease in Short Interest

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 8,900 shares, a decrease of 68.2% from the May 15th total of 28,000 shares. Based on an average trading volume of 75,800 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company's shares are short sold.

Fresenius SE & Co. KGaA Trading Down 1.3%

FSNUY stock traded down $0.17 during mid-day trading on Friday, reaching $12.68. The company had a trading volume of 17,998 shares, compared to its average volume of 56,989. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.36 and a quick ratio of 1.05. The company has a market capitalization of $28.33 billion, a PE ratio of 66.74 and a beta of 0.76. The firm has a 50 day moving average of $11.86 and a 200 day moving average of $10.43. Fresenius SE & Co. KGaA has a 12 month low of $7.43 and a 12 month high of $12.91.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.22 by $0.01. The business had revenue of $5.92 billion for the quarter, compared to the consensus estimate of $5.41 billion. On average, equities analysts predict that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current fiscal year.

Fresenius SE & Co. KGaA Increases Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, June 4th. Stockholders of record on Wednesday, May 28th were paid a dividend of $0.1827 per share. The ex-dividend date was Tuesday, May 27th. This is an increase from Fresenius SE & Co. KGaA's previous dividend of $0.17. This represents a dividend yield of 1.48%. Fresenius SE & Co. KGaA's dividend payout ratio (DPR) is currently 94.74%.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley restated an "overweight" rating on shares of Fresenius SE & Co. KGaA in a research note on Thursday, May 15th.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.